Toxoplasmosis is an infection caused by a one-celled parasite called Toxoplasma gondii. When a pregnant woman contracts toxoplasmosis, she can pass the infection on to her fetus. Between 400 and 4,000 babies in the United States are born with the infection each year (1, 2). Many infected babies develop serious complications, including vision and learning problems. A woman can get toxoplasmosis by eating raw or undercooked meat or by contact with cat feces. Fortunately, a pregnant woman can follow some simple precautions that can reduce her chances of becoming infected. Because more than half of all pregnancies are unintended, all women who could become pregnant should follow these precautions. What symptoms does toxoplasmosis cause in the baby? Without treatment, about 85 percent of infected babies who appear normal at birth develop problems months to years later (3, 4). These include eye infections that may affect sight, learning disabilities and hearing loss. Toxoplasmosis during pregnancy also can result in miscarriage, preterm delivery or stillbirth. (3, 5) How common is toxoplasmosis? Active infection normally occurs only once in a lifetime, followed by life-long immunity (protection). Although the parasite remains in the body indefinitely, it generally is harmless and inactive unless the immune system is not functioning properly (for example, if an individual has AIDS). Women who develop immunity to the infection before pregnancy are not in danger of transmitting it to their babies. Can a woman find out if she is immune? Women planning to become pregnant can discuss with their health care providers whether being tested before pregnancy is appropriate. If the blood tests show that a woman has not been infected, she should take precautions to prevent the infection during pregnancy, as should all women who have not been tested. How can a woman prevent toxoplasmosis during pregnancy?Cat feces and raw or undercooked meat are the most important sources of this infection. A pregnant woman can help prevent toxoplasmosis by avoiding known sources of infection:
How is toxoplasmosis diagnosed and treated during pregnancy? If the reference laboratory confirms that a pregnant woman has an active infection, the next step is to determine whether the fetus is infected. Prenatal tests, including amniocentesis and ultrasound, may help to determine whether the fetus is infected. If a fetus is suspected of being infected, the mother will be treated with the drugs pyrimethamine and sulfadiazine. This approach appears to reduce the frequency and severity of the newborn's symptoms (3, 4). The earlier the mother is treated, the less likely her baby is to have symptoms. If tests show that the fetus is not yet infected, the mother may be given an antibiotic called spiramycin. Some studies suggest that spiramycin can reduce by about 60 percent the likelihood of the fetus becoming infected (3, 4). Spiramycin has not been approved for use in this country by the Food and Drug Administration (FDA) and is considered an experimental drug. However, providers can obtain it through the FDA by calling (301) 827-2335 (7). How likely is an infected pregnant woman to pass toxoplasmosis on to her baby? How are infected newborns treated? A study by the U.S. National Collaborative Treatment Trial found that about 75 percent of infected babies (including those with severe infections present at birth) who received this treatment had normal intelligence, and none developed hearing loss (3). Unfortunately, this and other studies found that eye infections tended to recur in childhood (3, 8). Children who were re-treated with the two drugs generally did not suffer vision loss. Some treated babies still developed lasting disabilities, possibly because drug treatment may not reverse any brain or eye damage that occurred before birth. Most infected babies who do not have symptoms at birth miss early treatment. They often are not diagnosed until they develop an eye infection or other problems, sometimes months or years after birth. Currently, two states (Massachusetts and New Hampshire) screen newborns for toxoplasmosis, allowing for early treatment of infected newborns. References 2. Jones, J.L., et al. Toxoplasma Gondii Infection in the United States, 1999-2000. Emerging Infectious Diseases, volume 9, number 11, 2003. 3. Remington, J.S., et al. Toxoplasmosis, in Remington, J.S., Klein, J.O. (eds.): Infectious Diseases of the Fetus and Newborn Infant, 5th edition, Philadelphia, W.B. Saunders, 2001, pages 205-346. 4. Montoya, J.G., Liesenfeld, O. Toxoplasmosis. Lancet, volume 363, June 12, 2004, pages 1965-1976. 5. Freeman K., et al. Association Between Congenital Toxoplasmosis and Preterm Birth, Low Birthweight and Small for Gestational Age Birth. British Journal of Obstetrics and Gynecology, volume 112, number 1, January 2005, pages 31-37. 6. Centers for Disease Control and Prevention (CDC). Toxoplasma Infection Fact Sheet, accessed 6/3/05. 7. Food and Drug Administration (FDA). FDA Public Health Advisory: Limitations of Toxoplasma IgM Commercial Test Kits. FDA, July 25, 1997, accessed 6/2/05. 8. Wallon, M., et al. Long-Term Ocular Prognosis in 327 Children with Congenital Toxoplasmosis. Pediatrics, volume 113, number 6, June 2004, pages 1567-1572.
|
||||
| © 2008 March of Dimes Foundation. All rights reserved. The March of Dimes is a not-for-profit organization recognized as tax-exempt under Internal Revenue Code section 501(c)(3). Our mission is to improve the health of babies by preventing birth defects, premature birth, and infant mortality. | ||||
